Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Rentech(RTK) - gas-to-liquids and cleaner fuel -- Ignore unavailable to you. Want to Upgrade?

To: TokyoMex who wrote (1374)	2/23/1998 5:20:00 PM
From: Andrew H	Read Replies (1) \| Respond to of 14347

Mark from RNTK IR just got back to me. He reiterated there is an anti-shorting clause for the Series A preferred which extends to third parties as well as the buyers. He further stated that the Series B is not bottomless although the language in the Quarterly does not make that clear. Also both the Series A and B have restrictions on how many of the shares can be converted at any one time to prevent any dumping on the market. The company is planning to use these funds for certain acquisition opportunities that are arising. We may hear more about these before long. He also said he expected the company to be profitable by the end of this year and that they were not merely going to rely on GTL. As for the TX deal, he expressed considerable optimism and reiterated that negotioations were at an advanced stage, but he did caution that shareholders should consider it as an "if" and not a "when." His point was that until a deal is signed, one cannot really say "when." He said management would be in Singapore and India for the next month or so. I also asked him about GTL technology and the price of oil. He said as far as the refinery processes were concerned, with the iron based catalyst process, the price of oil was not really relevant. Anyone requiring any more details, information or reassurance should call him directly at 303 298-8008.